

High-Risk Beta
This platform is experimental. Smart contracts are unaudited. Use at your own risk.
Turmeric is heralded for its anti-cancer and anti-inflammatory properties, but columnist Alice Klein finds that the evidence for this is shaky. Taking high doses of its curcumin extract in supplement form can be risky
Monday, 1 June 2026
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.